Repligen
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 40 in the most recent period (2026/Q3).
- Total institutional ownership fell 5.3 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 118.27% -5.26pp
- Institutions
- 607 +40
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 30 buys · 20 sells
| Name | Role | Stake |
|---|---|---|
| Karen Dawes | Former Independent Director | 0.14% |
| Glenn Muir | Independent Director | 0.06% |
| Ralf Kuriyel | Officer | 0.01% |
| James Bylund | Chief Operating Officer | 0.01% |
| Martin Madaus | Independent Chairperson | 0.01% |
| Carrie Eglinton Manner | Independent Director | 0.01% |
| Nicholas Barthelemy | Independent Director | 0.01% |
| Rohin Mhatre | Independent Director | 0.01% |
| Jason Garland | CFO & Chief Compliance Officer | 0.01% |
| Konstantin Konstantinov | Member of Scientific Advisory Board & Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Brian Douglass | Senior VP & Chief Product Officer | Other Acquisition | +700 | -- |
| 2026-10-05 | Brian Douglass | Senior VP & Chief Product Officer | Other Derivative Acquisition | +675 | $174.86 |
| 2026-10-04 | Olivier Loeillot | Chief Executive Officer | Open Market Disposition | -1,333 | $178.75 |
| 2026-10-04 | Olivier Loeillot | President & Chief Commercial Officer | Intent to Sell (Form 144) | -4,202 | $190.00 |
| 2026-10-04 | Olivier Loeillot | President & Chief Commercial Officer | Intent to Sell (Form 144) | -1,333 | $178.75 |
| 2026-10-04 | Olivier Loeillot | Chief Executive Officer | Derivative Exercise and Sale | -4,202 | $154.96–190.00 |
| 2026-10-01 | Olivier Loeillot | Chief Executive Officer | Sale to Issuer | -1,248 | $181.70 |
| 2026-09-24 | Jason Garland | CFO & Chief Compliance Officer | Sale to Issuer | -421 | $189.68 |
| 2026-09-23 | Olivier Loeillot | Chief Executive Officer | Derivative Exercise and Sale | -12,946 | $154.96–190.00 |
| 2026-09-20 | Olivier Loeillot | Chief Executive Officer | Derivative Exercise and Sale | -5,426 | $141.79–180.00 |
| 2026-09-03 | Olivier Loeillot | Chief Executive Officer | Automatic Disposition | -3,035 | $165.90 |
| 2026-09-02 | Olivier Loeillot | Chief Executive Officer | Sale to Issuer | -2,842 | $169.61 |
| 2026-08-31 | Violetta Hughes | Chief Accounting Officer | Sale to Issuer | -277 | $170.02 |
| 2026-08-19 | Olivier Loeillot | Chief Executive Officer | Derivative Exercise and Sale | -5,426 | $141.79–180.00 |
| 2026-07-15 | Jason Garland | CFO & Chief Compliance Officer | Automatic Disposition | -530 | $150.00 |
| 2026-06-24 | Jason Garland | CFO & Chief Compliance Officer | Automatic Disposition | -733 | $145.00 |
| 2026-05-13 | Glenn Muir | Independent Director | Other Acquisition | +995 | -- |
| 2026-05-13 | Glenn Muir | Independent Director | Other Derivative Acquisition | +2,239 | $103.38 |
| 2026-05-13 | Martin Madaus | Independent Chairperson | Other Acquisition | +995 | -- |
| 2026-05-13 | Martin Madaus | Independent Chairperson | Other Derivative Acquisition | +2,239 | $103.38 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Repligen discussion 0 comments